182 related articles for article (PubMed ID: 19444092)
1. Ranolazine improves endothelial function in patients with stable coronary artery disease.
Deshmukh SH; Patel SR; Pinassi E; Mindrescu C; Hermance EV; Infantino MN; Coppola JT; Staniloae CS
Coron Artery Dis; 2009 Aug; 20(5):343-7. PubMed ID: 19444092
[TBL] [Abstract][Full Text] [Related]
2. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
Enseleit F; Sudano I; Périat D; Winnik S; Wolfrum M; Flammer AJ; Fröhlich GM; Kaiser P; Hirt A; Haile SR; Krasniqi N; Matter CM; Uhlenhut K; Högger P; Neidhart M; Lüscher TF; Ruschitzka F; Noll G
Eur Heart J; 2012 Jul; 33(13):1589-97. PubMed ID: 22240497
[TBL] [Abstract][Full Text] [Related]
3. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease.
Staniloae C; Mandadi V; Kurian D; Coppola J; Bernaski E; El-Khally Z; Morlote M; Pinassi E; Ambrose J
Cardiology; 2007; 108(3):164-9. PubMed ID: 17077630
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
[TBL] [Abstract][Full Text] [Related]
7. Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
Takayama T; Hiro T; Yoda S; Fukamachi D; Haruta H; Kogo T; Mineki T; Murata H; Oshima T; Hirayama A
Heart Vessels; 2018 Jun; 33(6):590-594. PubMed ID: 29209775
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
[TBL] [Abstract][Full Text] [Related]
9. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
10. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease.
Kang SM; Chung N; Kim JY; Koo BK; Choi D; Jang Y; Cho SY
Echocardiography; 2002 Nov; 19(8):661-7. PubMed ID: 12487635
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
Atherosclerosis; 2015 Jun; 240(2):351-4. PubMed ID: 25875387
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
[TBL] [Abstract][Full Text] [Related]
13. Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
Lai J; Wu B; Sun J; Shang Y; Zhu J
Coron Artery Dis; 2013 Nov; 24(7):566-71. PubMed ID: 23994882
[TBL] [Abstract][Full Text] [Related]
14. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
15. Comparison of peripheral arterial tonometry and flow-mediated vasodilation for assessment of the severity and complexity of coronary artery disease.
Woo JS; Jang WS; Kim HS; Lee JH; Choi EY; Kim JB; Kim WS; Kim KS; Kim W
Coron Artery Dis; 2014 Aug; 25(5):421-6. PubMed ID: 24584030
[TBL] [Abstract][Full Text] [Related]
16. Digital assessment of endothelial function and ischemic heart disease in women.
Matsuzawa Y; Sugiyama S; Sugamura K; Nozaki T; Ohba K; Konishi M; Matsubara J; Sumida H; Kaikita K; Kojima S; Nagayoshi Y; Yamamuro M; Izumiya Y; Iwashita S; Matsui K; Jinnouchi H; Kimura K; Umemura S; Ogawa H
J Am Coll Cardiol; 2010 Apr; 55(16):1688-96. PubMed ID: 20394872
[TBL] [Abstract][Full Text] [Related]
17. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease.
Sokol SI; Srinivas V; Crandall JP; Kim M; Tellides G; Lebastchi AH; Yu Y; Gupta AK; Alderman MH
Vasc Med; 2012 Dec; 17(6):394-404. PubMed ID: 23184900
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry.
Kandhai-Ragunath JJ; Doggen CJ; Jørstad HT; Doelman C; de Wagenaar B; IJzerman MJ; Peters RJ; von Birgelen C
Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):664-71. PubMed ID: 27068872
[TBL] [Abstract][Full Text] [Related]
19. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
20. The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine.
Karwatowska-Prokopczuk E; Wang W; Cheng ML; Zeng D; Schwartz PJ; Belardinelli L
Europace; 2013 Mar; 15(3):429-36. PubMed ID: 23258816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
